AmbioPharm, Inc - GMP Peptide Manufacturing Serivices and Development

AmbioPharm has multiple manufacturing suites to produce peptide APIs on gram to kilogram scale either by solid phase peptide synthesis, solution phase peptide synthesis, or hybrid solid/solution phase synthesis. AmbioPharm is currently validating a dedicated manufacturing line for a generic peptide API at kilogram scale scheduled for re-validation and commercial manufacturing in 2009 at 150-200 kg/year scale (25-50kg batches)